Cargando…

Disconnect for Tezepelumab on Exacerbations, Symptoms, and Quality of Life in Type 2 Low Asthma

Detalles Bibliográficos
Autores principales:	Lipworth, Brian, Chan, Rory
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395486/ https://www.ncbi.nlm.nih.gov/pubmed/37279364 http://dx.doi.org/10.1164/rccm.202304-0746LE

Ejemplares similares

Systemic IL-6 and Severe Asthma
por: Lipworth, Brian, et al.
Publicado: (2020)

Forced Vital Capacity and Low Frequency Reactance Area Measurements Are Associated with Asthma Control and Exacerbations
por: Chan, Rory, et al.
Publicado: (2022)

Don’t Forget about Facilitatory Effects of Corticosteroids on β(2)-Adrenoceptors in Acute Asthma
por: Lipworth, Brian, et al.
Publicado: (2020)

Sex Hormones and Asthma: Don’t Forget Progesterone
por: Lipworth, Brian, et al.
Publicado: (2020)

Baseline type 2 biomarker levels and response to tezepelumab in severe asthma
por: Corren, Jonathan, et al.
Publicado: (2022)

Dupilumab and tezepelumab in severe refractory asthma: new opportunities
por: Ragnoli, Beatrice, et al.
Publicado: (2022)

Efficacy and Potential Positioning of Tezepelumab in the Treatment of Severe Asthma
por: Plaza, Vicente, et al.
Publicado: (2023)

Inhaled corticosteroids and angiotensin-converting enzyme-2 in COPD
por: Lipworth, Brian, et al.
Publicado: (2021)

Mapping Impossible Utilities: The ICER Report on Tezepelumab for Severe Asthma
por: Langley, Paul C
Publicado: (2022)

Real-life effects of benralizumab on airway oscillometry in severe eosinophilic asthma
por: Chan, Rory, et al.
Publicado: (2023)

Inhaled Corticosteroids and COVID-19
por: Lipworth, Brian, et al.
Publicado: (2020)

High-dose budesonide for early COVID-19
por: Lipworth, Brian, et al.
Publicado: (2021)

Molecular Targets for Biological Therapies of Severe Asthma: Focus on Benralizumab and Tezepelumab
por: Cheng, Shih-Lung
Publicado: (2021)

Tezepelumab as an Emerging Therapeutic Option for the Treatment of Severe Asthma: Evidence to Date
por: Dorey-Stein, Zachariah L, et al.
Publicado: (2021)

Tezepelumab: A Potential New Biological Therapy for Severe Refractory Asthma
por: Pelaia, Corrado, et al.
Publicado: (2021)

Developments in the Management of Severe Asthma in Children and Adolescents: Focus on Dupilumab and Tezepelumab
por: van Dijk, Yoni E., et al.
Publicado: (2023)

The potential promise and challenge for tezepelumab as a biologic therapy for severe asthma
por: Williams, Dennis M
Publicado: (2022)

Resistance Heterogeneity and Small Airway Asthma Phenotype
por: Lipworth, Brian, et al.
Publicado: (2019)

COVID-19: Start with the nose
por: Lipworth, Brian, et al.
Publicado: (2020)

Type 2 Asthma Inflammation and COVID-19: A Double Edged Sword
por: Lipworth, Brian, et al.
Publicado: (2021)

Monitoring asthma in childhood: symptoms, exacerbations and quality of life
por: Brand, Paul L.P., et al.
Publicado: (2015)

Tezepelumab for Patients with Severe Uncontrolled Asthma: A Systematic Review and Meta-Analysis
por: Zoumot, Zaid, et al.
Publicado: (2022)

Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR
por: Laidlaw, Tanya M, et al.
Publicado: (2023)

Tocilizumab for severe COVID-19 pneumonia
por: Lipworth, Brian J, et al.
Publicado: (2020)

Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: A Post Hoc Analysis of the PATHWAY Phase 2b Study
por: Corren, Jonathan, et al.
Publicado: (2021)

Tezepelumab treatment for allergic bronchopulmonary aspergillosis
por: Ogata, Hiroaki, et al.
Publicado: (2023)

Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes
por: Watchorn, David, et al.
Publicado: (2021)

The Impact of Tezepelumab in Uncontrolled Severe Asthma: A Systematic Review of Randomized Controlled Trials
por: Roy, Pooja, et al.
Publicado: (2022)

Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR [Corrigendum]
Publicado: (2023)

Impact of Biologic Therapy on the Small Airways Asthma Phenotype
por: Chan, Rory, et al.
Publicado: (2022)

Medium-term repeatability for airwave oscillometry in patients with severe asthma taking benralizumab
por: Chan, Rory, et al.
Publicado: (2023)

Effectiveness of bronchial thermoplasty in patients with asthma exhibiting overweight/obesity and low quality of life
por: Nishi, Kenta, et al.
Publicado: (2023)

Research & policy disconnect: The case of rabies research in India
por: Abbas, Syed Shahid, et al.
Publicado: (2013)

The ultra-connected generation would like to disconnect now
por: Cassan, Julie, et al.
Publicado: (2021)

Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study
por: Menzies-Gow, Andrew, et al.
Publicado: (2023)

Oscillometry bronchodilator response in adult moderate to severe eosinophilic asthma patients: A prospective cohort study
por: Chan, Rory, et al.
Publicado: (2022)

Reply to Watchorn et al.: Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes
por: Foer, Dinah, et al.
Publicado: (2021)

Disconnection of pulmonary and systemic arterial stiffness in COPD
por: Weir-McCall, Jonathan R, et al.
Publicado: (2018)

Functionality and Performance of an Accessorized Pre-Filled Syringe and an Autoinjector for At-Home Administration of Tezepelumab in Patients with Severe, Uncontrolled Asthma
por: Alpizar, Sady, et al.
Publicado: (2021)

The efficacy and safety of tezepelumab in the treatment of uncontrolled asthma: A systematic review and meta-analysis of randomized controlled trials
por: Lin, Fei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_11387rbcqcec8vmn3jie665igk